A s one of the most powerful noninvasive diagnostic techniques, magnetic resonance imaging (MRI) is widely applied for clinical whole body imaging and can provide anatomical and functional information about soft tissues and organs with excellent spatial resolution. The signal intensity in MRI, corresponding to the magnetic relaxation rate of water protons, could be enhanced by appropriate exogenous contrast agents. There are two principal relaxation processes: longitudinal (T 1 recovery, spinÀlattice) or transverse (T 2 decay, spinÀspin) relaxation. T 1 recovery generates positive contrast, but T 2 decay reduces the imaging intensity, resulting in negative contrast. 1 The introduction of exogenous contrast agents could accelerate the relaxation process of either T 1 or T 2 , thereby enhancing the imaging contrast. Common T 1 contrast agents are paramagnetic complexes containing gadolinium (Gd 3þ ), manganese (Mn 2þ ), or iron (Fe 3þ ) ions. 2À7 Those relatively small molecules usually have a short circulation time, due to their fast renal excretion. They leave the vascular system within a few minutes, making it relatively hard to have a high resolution image acquisition. Moreover, the use of functionalized paramagnetic complexes as targeting contrast agents is limited because of the arduous and lengthy modification process and poor detection sensitivity. On the other hand, the superparamagnetic iron oxide nanoparticles (SPIOs) as T 2 MR contrast agents are very useful for biomedical applications as they are not subject to strong magnetic interactions in dispersion and are readily stabilized under physiological conditions. 4, 8 As T 2 -weighted contrast reagents, SPIOs can be magnetically saturated in the normal range of magnetic field strengths used in MRI scanners, thereby establishing a substantial locally perturbed dipolar field that leads to a remarkably shortening of proton relaxation of the surrounding solid tissue area. 1, 9 However, due to the negative contrast effect and susceptibility artifacts, distinguishing the region of signals induced by SPIOs from low-level background MR signals arising from adjacent tissues such as bone or vasculature is a major challenge, especially when the signal-to-noise ratio is low. Recently, T 1 /T 2 contrast agents have been developed and actively studied for dual T 1 and T 2 mode MRI, because they have the ability to validate reconstruction and visualization of the data in an accurate and reliable manner, and to acquire complementary and selfconfirmed information to permit meaningful interpretation. 10 Several approaches have been applied to develop T 1 /T 2 contrast agents. In the first approach, some nanomaterials could intrinsically show both T 1 and T 2 contrast effects in the dual mode MRI but also suffer certain limitations. For instance, ultrasmall SPIOs (∼3 nm size) display great potential as T 1 contrast agents, but their T 2 contrast effect is weak. 11 FeCo alloy nanoparticles (NPs) exhibit both high T 1 and T 2 contrast effects and the mechanism underlying this phenomenon is still unclear. 12 As paramagnetic materials, several lanthanide (Ln) oxide NPs (Ln = Gd, Dy, and Ho) and manganese oxide NPs have been extensively studied as potential candidates for either T 1 or T 2 MRI contrast agent or both. 5,13À19 Compared to either regular T 1 or T 2 contrast agents, the MRI contrast effects of Ln oxide NPs are relatively weak at the same scanning condition. Moreover, their acute and chronic toxicity remain unclarified. In the second approach, in order to combine both T 1 and T 2 contrast effect together, Park and coworkers used Gd-labeled magnetite (Fe 3 O 4 ) NPs as contrast agents for dual T 1 and T 2 weighted MRI. 20 Later,
Cheon and co-workers found that the magnetic coupling induced by T 2 /T 1 -core/shell structures can result in undesirable quenching of both T 1 and T 2 signals in MRI images. 10 They then optimized the thickness of silica shell to modulate the degree of T 1 and T 2 coupling, thereby leading to a significant increase in T 1 contrast effect, but the T 2 contrast effect still lost one-third of original value because the thick silica shell dramatically reduces the magnetic field to the surrounding water molecules. 10 On the basis of the similar IONP/silica core/ shell structures, Yang and co-workers recently designed the dual-contrast T 1 and T 2 -weighted MR contrast agents modified with an arginineÀglycineÀaspartic acid (RGD) peptide for selectively targeting R v β 3 overexpressed tumor in vitro and in vivo. 21 The interference inevitably occurs when both T 1 and T 2 contrast agents are integrated into a single composite, especially when they are in close proximity. Although the conventional core/shell structures could efficiently reduce their magnetic coupling by introducing a separating layer between them (Figure 1a , left panel), the T 2 contrast effect is compromised as the thick shell decreases the magnetic field to the surrounding water molecules. In this study, we first developed a synthetic strategy for engineering the architecture of heterogeneous nanoparticles, which could help us to further understand the magnetic coupling at the nanoscale. After gaining insight from the synthesis strategies, we chose dumbbell-like NPs or so-called 'Janus' NPs, which have two different components within one single structure, as solid-state analogues of bifunctional organic molecules to construct hybrid nanotrimers (HNTs) (Figure 1a , the right panel), in which iron oxide and gold nanocrystals are connected with a platinum nanocube. In our previous study, dumbbell-like heteronanostructures with two different nanomaterials (Au and iron oxide: AuÀIO) within one hybrid structure also showed capability of combining two different moieties together for dual modal imaging. 23 In this study, the surface of Au component in AuÀIO NPs were then modified with Gd to test its use for T 1 /T 2 MRI. However, induced T 1 contrast effect could be adversely affected by the attenuation of local magnetic field because there is a strong magnetic coupling between iron oxide and Gd species in the structure of the dumbbell-like AuÀIO NPs. To reduce the undesired magnetic coupling effect, we designed a strategy to build such HNTs to combine both T 1 and T 2 contrast agents together by fusing IONP, Pt, and gold nanocrystals via solid-state interfaces ( Figure 1b) . The size of gold nanocrystals could be further enlarged by controlling the seed-mediated and epitaxial growth processes during the synthesis. Meanwhile, we optimized the sizes of Pt cubes to adjust the distance of IONP and gold nanocrystals in order to manipulate the magnetic coupling effect. The resultant heterotrimers with large gold crystals show real dumbbell morphology, which are named as dumbbell-hybrid nanotrimers (DB-HNTs). Ones with a large center-to-center distance between gold and iron oxide are called as extra large dumbbell-hybrid nanotrimers (XDB-HNTs). The iron oxide components were modified with polyethylene glycol (PEG) chains to make the whole NPs water-soluble and biocompatible. The surface of gold were covalently immobilized with Gd chelators (dithiol derivative 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid ARTICLE (DOTA) chelator, or cystamine-DOTA 2 , Supporting Information Figure S1 ). The resultant hybrid heterostructures could induce both simultaneous positive and negative contrast enhancement in MR images. The in vivo biodistribution of hybrid heterostructures favorable for molecular imaging was confirmed using small animal PET. The potential of GdÀDB-HNTs as dual contrast agents for T 1 and T 2 -weighted MRI was demonstrated by conducting in vitro relaxivity measurements and in vivo imaging.
RESULTS AND DISCUSSION
Synthesis and Characterization of Dumbbell Hybrid Heteronanostructures. The syntheses of complex hybrid heteronanostructures sequentially involved a set of the seed-mediated nucleation and epitaxial growth processes. According to the previously published procedures with a slight modification, 23À25 the monodisperse AuÀIONP heterodimers were synthesized by thermal decomposition of iron precursor 
ARTICLE
(iron pentacarbonyl) onto 5 nm polyhedral gold nanospheres in the presence of surfactants (oleic acid and oleylamine), followed by a controlled oxidation. When cubic Pt nanoparticles (4 nm Pt NPs) were used as seeds, the site-selective heterogeneous nucleation and epitaxial growth resulted in the formation of PtÀIONP heterodimers, 26, 27 which showed uniform heterodimer morphology with a narrow size distribution (Supporting Information Figure S2 ). Here, by using PtÀIONPs as building blocks, we have successfully prepared HNTs with size-tunable Au components ( Figure 1dÀf ). Typically, in the presence of PtÀIONP heterodimers as seeds, the reduction of gold precursor [hydrogen tetrachloroaurate(III) (HAuCl 4 )] with oleylamine in a mild temperature results in the heterogeneous nucleation of Au on the Pt components. Such selective overgrowth of gold on the PtÀIONP seeds is attributed to both the lattice matching between Pt and Au components, and the stress energy accumulated at the heterogeneous interface between gold and iron oxide. 28, 29 The HNTs were observed as heterotrimer morphology in approximately 85% yield (a minimum of 200 discrete particles were measured from each of at least two widely separated regions of the sample) in the transmission electron microscopy (TEM) images (Figure 1d ). The average diameter of spherical Au components of HNTs is approximately 7.0 ( 0.4 nm. To increase the size of Au components, an extra amount of gold precursor is added during the synthesis under a similar condition. As seen in Figure 1e ,i, Au components of the resultant dumbbell HNTs (DB-HNTs) have average diameters of 9.1 ( 0.6 nm ( Table 1) . To manipulate the magnetic coupling effect, we optimized the sizes of cubic Pt nanocrystals to adjust the distance of iron oxide components and gold nanocrystals. When 5 nm Pt nanocubes were used as seeds (Supporting Information Figure S2 ), we could end up with getting extra large dumbbell HNTs (XDB-HNTs) (Figure 1f,j) . As shown in Table 1 , the center-to-center distance between iron oxide and gold nanocrystal (D Au-to-IO ) was significantly increased when large gold nanocrystals were grown on the Pt seeds. As expected, the large 5 nm Pt nanocubes created the longest distance (12.9 ( 0.7 nm) between iron oxide and gold within XDB-HNTs. Although much bigger HNTs with similar dumbbell shapes could be obtained when the 7 nm cubic Pt particles were used as seeds, two or more gold crystals could grow on Pt cubes to form complex heterostructures (Supporting Information Figure S6 ), which could adversely influence the quality of the products. In short, all four heterostructures (AuÀIONP, HNTs, DB-HNTs, and XDB-HNTs) share a structural similarity, a dumbbell shape, in which either Au component is embedded into IONP, or Au and IONP are connected via a robust Pt spacer. Surface Coating and Gd Chelating of Hybrid Heteronanostructures. A surface modification step is necessary to provide the NPs water-soluble, biocompatible and functionalizable. According to our previously published procedure, 23 all four hybrid heterostructures were coated with biocompatible PEG chains in order ARTICLE to circumvent the known scavenging effects of the mononuclear phagocyte system (MPS) and to prolong their blood circulation half-life. Such PEGylation process refers to the approach of the ligand exchange in which the bidentate ligand (dopamine) terminated PEG (MW ∼ 5000 Da, Supporting Information Figure S8 ) chains were covalently attached onto the surface of IONP components. It enables the phase transfer of the NPs from organic solvents to an aqueous solution, and renders the NPs with great stability against agglomeration in physiological conditions. More importantly, it provides functional groups or moieties for potential targeting modification. Because of significant differences in the surface chemistry properties between Au and iron oxide components, the Au surface could be selectively modified by well-defined functional groups without any interference from the other components of heterostructures. Here, a dithiol derivative DOTA chelate (cystamineÀ DOTA 2 , Supporting Information Figure S1 ) was synthesized and immobilized on the Au surfaces via a strong goldÀsulfur interaction. Combining two DOTA molecules via a dithiol linker could guarantee the maximum coverage of DOTA chelates on the gold surface ( Table 1 ). The DOTA modified heterostructures were then conjugated with Gd 3þ by mixing solution of NPs with a large excess of aqueous solution of GdCl 3 . After purification, the amount of each element in the resultant Gd-incorporated NPs was determined by inductively coupled plasmaÀmass spectroscopy (ICPÀMS). As listed in the Figure S10 ). A significant increase in size from 19 to 27 nm was attributed to the epitaxial growth of gold components on Pt crystals. After the gold components were coated with negatively charged DOTA ligand, zeta potential measurements clearly showed that all four types of heterostructures had negative surface potentials (Table 1) . Subsequent complexation with Gd ions gave rise to a remarkable increase in surface zeta potentials of all four NPs (Supporting Information Figure S12 ), due to the neutralization of the negative surface charge caused by the coordination of cationic Gd ions with carboxylate groups of DOTA ligands.
Magnetic Resonance (MR) Phantom Test. To evaluate the feasibility of using various Gd incorporated HNTs as dual T 1 -and T 2 -weighted contrast agents, we measured their relaxivities in aqueous medium on a 7.0 T MR scanner. Figure 3 shows the T 1 -weighted MR images of GdÀAuÀIONPs, GdÀHNTs, GdÀDB-HNTs, and GdÀXDB-HNTs at different concentrations based on iron contents. Both GdÀDB-HNTs and GdÀ XDB-HNTs displayed a signal enhancement on the T 1 -weighted images with a concentration-dependent manner. It is noticed that their contrast effects are more significant than that of GdÀHNTs at the same condition, but there is almost no T 1 contrast effect observed for GdÀAuÀIONPs. Although the larger Au surface area could result in the more Gd loading, the distance between Au and IONP components played an important role in regulating the magnetic coupling effect so that both GdÀDB-HNTs and GdÀXDB-HNTs provided the most significant contrast effect among these heterostructures. To quantitatively determine the MR contrast effect, the relaxivity coefficient (r 1 ) was calculated from T 1 mapping images acquired by using an inversion recovery sequence. On the basis of the total concentrations of both Fe and Gd, the r 1 For GdÀHNTs, however, the T 1 MR contrast effect was quenched to some extent because the coupling between electron spins of the Gd complex and nuclear spins of water was perturbed by the additional magnetic field generated by nearby iron oxide components. 10 Such quenching effect could be remarkably reduced by enlarging the distance between T 1 and T 2 contrast agents (or D Au-to-IO ). In this case, with an increase in the size of gold components, the percentage of Gd-complex immobilized on gold surface away from the iron oxide components gradually increased, thereby resulting in reduction of the quenching effect. In a similar manner, the interaction between the T 1 and T 2 contrast agents could be efficiently separated or attenuated using large Pt nanocubes. With the larger center-to-center distance between iron oxide and gold component, GdÀXDB-HNTs provided higher r 1 value than GdÀDB-HNTs. Both GdÀDB-HNTs and GdÀXDB-HNTs showed obvious T 1 contrast effect among four heterostructures. On the other hand, the iron oxide components in the heterostructures can serve as T 2 contrast enhancement agents. Since all four heterostructures have iron oxide components with similar sizes and shapes, their T 2 weighted MR images at a same iron concentration gradient (in the range from 0 to 0.5 mM) displayed similar contrast effects (Figure 4b) . Accordingly, the relaxivity coefficients (r 2 ) of GdÀAuÀIONPs, GdÀHNTs, GdÀDB-HNTs, and GdÀXDB-HNTs were calculated from T 2 mapping images (Table 3) . Because the sizes of iron oxide components are roughly close, they all have similar relaxivities, which are close to that of a commercial available T 2 contrast agent (Feridex, 158.3 mM À1 /s).
It suggests that all heterostructures with iron oxides can be efficiently used as T 2 contrast agents. Moreover, there are no significant changes in relaxivity of Gdchelated NPs compared to that of unchelated NPs, indicating that the T 2 relaxation process induced by magnetic iron oxide cores could not be adversely influenced by the Gd-coating on the nearby Au components. Interestingly, there is a slight decrease in relaxivity coefficient with a decrease in the size of iron oxide component (Tables 1 and 3) , probably due to both thermal agitation and the surface spin canting of small iron oxide particles. Finally, the ratios of r 2 to r 1 are calculated in order to estimate the efficiency of both T 1 and T 2 contrast effects of all the heterostructures. For the purpose of comparison, we determined each relaxivity of contrast agent with each element content. For example, the calculation of the r 1 relaxivity of each particle is based on different concentrations of Gd. They are listed as r 1 0 values in Table 3 . Even though the r 2 /r 1 ratio of GdÀDB-HNTs was 33, their r 2 /r 1 0 ratio was only 4.2, indicating that they could be both efficient T 1 and T 2 contrast agents. Although GdÀXDB-HNTs have slightly higher r 1 0 values, they do not have better r 2 /r 1 ratio than GdÀDB-HNTs because of their larger size of iron oxide component. Stability and Cytotoxicity. To validate the stability of functionalized heterostructures, we measured the hydrodynamic size distribution of functionalized DB-HNTs over the time course of a 48 h incubation in mouse serum using DLS. The average sizes of DB-HNTs remained same over the course of 48 h incubation, indicating that the DB-HNTs are stable in a physiological condition (Supporting Information Figure S11a ). We further validated the binding stability of Gd ions to the functionalized DB-HNTs by analyzing the trace amount of each element in the eluent/ supernatant of every aliquot from stability test ICP-MS, and found the free Gd 3þ was nearly undetectable (Supporting Information Figure S13 ). The absence of any free Gd ions in the eluent confirmed the strong binding of Gd ions to DOTA-conjugated DB-HNTs.
In vitro cytotoxicity of GdÀDB-HNTs was evaluated by a standard tetrazolium dye (MTT) based colorimetric assay of viability of a fibroblast cell line (NIH-3T3). As seen in Supporting Information Figure S11b , there was no obvious decrease in cell viability after the cells were ARTICLE incubated with GdÀDB-HNTs at various concentrations in the range of 1À200 μg Fe/mL for 24 and 48 h. The cell viability still remained above 90% for 24 h or 85% for 48 h even at the concentration of 200 μg Fe/mL, indicating that GdÀDB-HNTs are biocompatible and minimally cytotoxic in the given concentration range.
PET Imaging and Quantification. The in vivo behavior of DB-HNTs was then evaluated by positron emission tomography (PET). Instead of being chelated with Gd ions for MRI study, the DOTA molecules on the DBHNTs were efficiently labeled with PET radionuclide 64 Cu at a specific activity of 222 MBq/nmol particles (or 4 μCi/μg Fe) with a radiolabeling yield of 60À70%. A significant decrease (5.1%ID/g) in liver uptake after 24 h post-injection highlighted that NPs were able to be eliminated through hepatic excretion. More importantly, the kidney uptake of injected NPs was 3.5 ( 0.5%ID/g at 4 h post-injection and slightly increased to 4.1 ( 0.5%ID/g after 24 h post-injection, indicating that the renal excretion was also involved in the elimination process of NPs from mice. Even though XDB-HNTs have slightly bigger sizes than DB-HNTs, they show very similar in vivo behavior as DB-HNTs (Figure 4c,d) . The favorable in vivo distribution, tumor accumulation and clearance through both hepatobiliary and renal system indicate that the DB-HNTs is a novel type of highly promising NPs for in vivo applications. Dual T 1 and T 2 -Weighted MRI. To validate the ability of GdÀDB-HNTs as dual T 1 /T 2 mode MRI agents in living subjects, we performed the in vivo MRI of mice bearing HT-29 tumors injected via the tail vein with GdÀ DB-HNTs (200 μL, 8 mg Fe/kg mouse body weight). When administered in the bloodstream, the GdÀDB-HNTs favor extravasations through leaky vasculature due to their size and surface properties, followed by deep penetration and retention at the tumor sites, which is a phenomenon known as the Enhanced Permeability and Retention (EPR) effect. Figure 4e shows the transverse T 1 -and T 2 -weighted images of tumor before injection and at 4 h post-injection. Compared with the pre-injection images, T 1 -weighted tumor images showed obvious positive signal enhancement, while the tumor signal from T 2 -weighted images was getting much darker. Since the tumor appeared hyperintense relative to muscle on T 2 -weighted images before tail-vein injection of GdÀ DB-HNTs, it consequently became easily identifiable on the post-injection images because of the obvious hypointenses within the tumors. Such a significant change in contrast was attributed to the accumulation of the injected GdÀDB-HNTs in the tumor via the EPR effect. On the other hand, the hyperintense signal from the tumor sites on T 1 -weighted image after intravenous injection of particles further validated that GdÀDB-HNTs were accumulated within the tumor after 4 h. As seen in Figure 4e , the variation in the signal intensities on T 1 -weighted and T 2 -weighted images most likely reflected the inhomogeneities of tumors, such as tumor vessel, cell density, necrotic core, or susceptibility effects between tissues. Although calculated T 1 or T 2 maps could clearly identify those substantial changes in T 1 or T 2 values in the ROIs compared to the surrounding tissues, the quantification of the concentration of accumulated Gd ÀDB-HNTs within the tumors from T 1 or T 2 measurement is inexact, possibly due to the lack of correlation between the number of the particles and either T 1 or T 2 value, especially when monitoring tumor uptake overtime. 30 To obtain the reproducible and dependable results for signal intensity measurement, we manually drew ROIs covering the whole tumor volume on both T 1 -and T 2 -weighted images. According to quantification analysis of the MR signal in the tumors, there was a sharp increase (36%) in T 1 -weighted signal intensity after 4 h post-injection, while the T 2 -weighted signal intensity was decreased to 72% of initial scans (Figure 4f ). These results indicated that GdÀDB-HNTs provided both positive T 1 and negative T 2 contrast enhancement for MR tumor imaging. It is worth noting that, when the T 1 and T 2 contrast intensities are comparable, the dualcontrast effect probes could provide optimal contrasts on both T 1 -and T 2 -weighted images because of their synergistic combination of the two relaxation effects.
CONCLUSIONS
By fusing Au, Pt, and IONP nanocrystals together via solid-state interfaces, and selectively modifying distinct surfaces, we built hybrid nanotrimers to combine both T 1 and T 2 -weighted contrast agents together in a nanocomposite with desirable shape and size for dual MRI. We further manipulated the spatial arrangement of each component in order to control the distance between T 1 ARTICLE and T 2 species to reduce the magnetic coupling and synergistically enhance both T 1 /T 2 contrast effects. The novel nanostructures having both positive and negative contrast effects can be potentially used as molecular nanoprobes for tumor diagnostic and therapeutic applications with excellent accuracy and reliability.
METHODS
Materials. Hydrogen tetrachloroaurate(III) (HAuCl 4 ) and platinum(II) 2,4-pentanedionate (Pt(acac) 2 ) were ordered from Strem Chemicals, Inc. N-Hydroxysuccinimide (NHS), N-hydroxysulfosuccinimide (sulfo-NHS), and 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride (EDC) were purchased from Pierce Biotechnology. Iron pentacarbonyl [Fe(CO) 5 ], oleic acid (technical grade 90%), oleylamine (technical grade 90%), 1-octadecene (technical grade 90%), cystamine, and methoxyPEG glycol (mPEG 5000) were ordered from Sigma/Aldrich. The metal chelator, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid mono (Nhydroxysuccinimide ester), DOTA-NHS-ester, was obtained from Macrocyclics. Unless otherwise mentioned, all other chemicals were purchased from Sigma/Aldrich. All solvents and chemicals were used as received. The radioisotope Characterizations. Mass spectra of synthetic polymers were recorded by a time-of-flight (TOF) mass spectrometer (AB SCIEX TOF/TOF 5800, Applied Biosystems) equipped with a matrixassisted laser desorption ionization (MALDI) ion source. A CRC-15R PET dose calibrator (Capintec Inc., Ramsey, NJ) was used for all radioactivity measurements. Graphical image analysis was performed using ImageJ. The elemental analyses were performed using inductively coupled plasma mass spectrometer (ICPÀMS, Thermo Scientific Xseries 2 Quadrupole). The NP samples were suspended in freshly prepared aqua regia [trace metal grade 70% nitric acid HNO 3 /36% hydrochloric acid HCl (Fisher Scientific), 1:3 v/v] and heated until completely dissolved, and then diluted up to 8 mL with double-distilled water. The cells pallets, homogenized tissues and organs (no more than 500 mg) were digested in a microwave (CEM MarsXpress Microwave Digester with Teflon microwave-safe vessels) before ICP analysis. The high-resolution transmission electron microscope (HR-TEM) and scanning transmission electron microscope (STEM) images were recorded with a FEI Tecnai G2 F20 X-TWIN transmission electron microscope operating at 200 kV. Samples were deposited and dried on copper grids covered with a Formvar/carbon support film, followed by plasma cleaning.
Synthesis of AuÀIONPs. The dumbbell-like AuÀIONP heterodimers (AuÀIONP) were prepared using previously published procedure. 23 Synthesis of HNTs, Dumbbell HNTs (DB-HNTs), and Extra Large Dumbbell HNTs (XDB-HNTs). The 4, 5, and 7 nm cubic Pt NPs and PtÀIONP heterodimers (PtÀIONPs) were synthesized according to the procedures described in the previous publications.
26À28 The HNTs and DB-HNTs were prepared using a modified procedure. 27 Experimentally, 20 mg of hydrogen tetrachloroaurate(III) (HAuCl 4 ) was dissolved in 10 mL of 1-octadecene containing 0.5 mL of oleylamine in a 20 mL glass vial with vigorous stirring. Under a nitrogen flow, PtÀIONPs (10 mg) in 1 mL of hexane were quickly injected into the above solution at 80°C. The Au epitaxial overgrowth on PtÀIONPs was carried out at this temperature for 2 h to yield a purple-dark gray colloidal solution. After the mixture was cooled down to room temperature, the resultant DB-HNTs were precipitated by adding 40 mL of isopropyl alcohol and collected by centrifugation (5000 rpm, 5 min). When 5 nm cubic Pt NPs were used as seeds, the XDBHNTs were obtained by the same procedure. The HNTs were obtained by a similar procedure when 10 mg of HAuCl 4 was used as a gold precursor. The precipitated NPs were redispersed in 5 mL of hexanes in the presence of 0.02 mL of oleylamine, and were recollected by ethanol precipitation and centrifugation. The washing process was repeated twice and the final products were stored in hexanes (5 mL) in the presence of 0.02 mL of oleylamine.
Synthesis of CystamineÀDOTA 2 . The cystamine dihydrochloride (1.5 mg, 6.5 μmol) was dissolved in 0.2 mL of DMF containing 5 μL of N,N-diisopropylethylamine. Ten milligrams of DOTAÀ NHSÀester in 50 μL of DMF was added to the above solution. The resultant mixture was stirred for 4 h at room temperature and the completion of the reaction was monitored by Kaiser test and mass spectra. The final product was identified by MALDI-TOF (Supporting Information Figure S9) .
Synthesis of Methoxypolyethylene Glycol 5000 Acid (mPEG-5000-COOH). To a solution of methoxy polyethylene glycol 5000 (5 g, 1 mmol) in 30 mL of dry THF was slowly added sodium hydride (60%, 0.2 g, 5 mmol) at room temperature. The solution was stirred for 1 h at room temperature, and then ethyl bromoacetate (1.11 mL, 10 mmol) was added dropwise. The mixture was stirred at 50°C for 24 h. The solution was filtered and concentrated in vacuum. The residue was hydrolyzed with 20 mL of 1 M NaOH/methanol (1:1, v/v) for 6 h at room temperature. The resultant solution was acidified with 1 M HCl to pH 1.0, and the solvents were then removed under reduced pressure. The residue was dissolved in 10 mL of DCM and dried out in the presence of anhydrous sodium sulfate. The crude product was precipitated by adding cold ethyl ether and purified by chromatography to afford product mPEG-5000-COOH as a white powder.
Surface Modification of Various HNTs. Two milligrams of EDAC and 1.5 mg of NHS were added to the solution of the mPEG-5000-COOH (50 mg) in 2 mL of chloroform. The mixture was stirred at room temperature for 30 min, and 2 mg of dopamine in 1 mL of DMF with 2 mg of anhydrous sodium carbonate was then added. The resultant mixture was continuously stirred for 2 h at room temperature. Ten milligrams of dumbbell HNTs (HNTs, DB-HNTs, or XDB-HNTs) in 1 mL of chloroform was added to the above mixture with vigorous stirring. The resulting mixture was stirred at room temperature for 24 h. The PEGylated nanoparticles were precipitated by adding 15 mL of hexane, and collected by centrifugation. After a wash with hexane, the PEGylated HNTs were redissolved in 2 mL of chloroform. Ten milligrams of as-synthesized cystamineÀDOTA 2 in 1 mL of DMF was added to the solution. The resultant mixture was vigorously stirred for 24 h at room temperature. The modified HNTs were precipitated by adding 15 mL of hexane, and collected by centrifugation. The washing process was repeated twice. The NPs were dried under the nitrogen flow and redissolved in water. The NPs were purified by dialysis tubing (MWCO = 12 kDa). After a pass through 0.22 μm filter, the resultant NPs were concentrated using a spin filter (MWCO = 30 kDa). The concentrations of Au, Pt, and Fe were determined by ICPÀ MS analysis. The same procedure was used to modify AuÀIONP and HNTs.
TEM Analysis. The TEM images were recorded with a FEI Tecnai G2 F20 X-TWIN transmission electron microscope operating at 200 kV. Samples were deposited and dried on copper grids covered with a Formvar/carbon support film, followed by plasma cleaning. The crystal sizes of each component of HNTs were measured using TEM. The characterization of sizes of NPs by TEM was performed according to the standard assay protocol (NIST -NCL Joint Assay Protocol, PCC-7), including sample preparation, measurement and result analysis. A minimum of 200 discrete particles was measured from each of at least two widely separated regions of the sample. Version V1.46 of NIH ImageJ was used for image processing, analysis and measurements.
Stability Test. The colloidal stability of DB-HNTs in aqueous solution was studied by dynamic light scattering (Malvern Zeta Size Nano S-90 DLS instrument). The refractive indexes of gold ARTICLE and platinum were adapted from the Malvern Reference manual (MAN0396 Issue 1.0). The refractive index of 0.30 was adapted for gold, while the refractive index of platinum was 4.5. The stability of functionalized DB-HNTs was validated by measuring the hydrodynamic size distribution of functionalized DB-HNTs in serum using DLS. The DB-HNTs were added to mouse serum in phosphate buffered saline (PBS) at a concentration of 4 nM and then incubated at 37°C for 24 h. The aliquots were analyzed at 0, 4, 8, 24 , and 48 h post-incubation by DLS. Each aliquot was filtered using a spin filter (MWCO = 30 kDa), and further washed with water 3 times. The eluent was collected and analyzed by ICP-MS for trace amount of Fe, Pt, Au and Gd.
Cytotoxicity Assay. Cytotoxicity of GdÀDB-HNTs was evaluated by using a cell viability assay (MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (Sigma-Aldrich, St. Louis, MO))). Briefly, NIH-3T3 cells were plated into a 96-well plate at a concentration of 6 Â 10 3 cells/well in DMEM with 10% fetal bovine serum (FBS) at 37°C and 5% CO 2 , and 24 h later, the cells were incubated with GdÀDB-HNTs with different concentrations in DMEM for 24 and 48 h. The cell viability assays were carried out according to the manufacturer's instruction. After treatment, MTT compound (5 mg/mL in PBS) was diluted 1:100 with DMEM medium into each well. After 3 h incubation, culture supernatants were carefully removed, and the purple reduced MTT product was redissolved in 100 μL of DMSO in 10 min. The concentration of the reduced MTT in each well was determined spectrophotometrically at 540 nm with a reference wavelength of 650 nm using a microplate reader (TECAN Infinite M100). All samples were done in tetraplicate and all experiments were repeated 3À5 times. MTT absorbance values were normalized to 100%; experimental values (treated) were expressed as percentage of the control. Significant differences between sets of values for control and test groups were assessed by Student's t test.
Gd Chelating of DOTA-Modified DB-HNTs or XDB-HNTs. The gadolinium chloride solution (100 μL of 10 mM in 0.1 M sodium acetate buffer (pH = 6)) was added to 0.5 mL of 150 nM DOTA DB-HNTs solution with 100 μL of 0.1 M sodium acetate buffer in a microcentrifuge tube. The tube was incubated at a 42°C water bath overnight for the chelating reaction. The unbound Gd ions were removed by using a PD-10 column. The eluent was concentrated using a spin filter (MWCO = 30 kDa), and further washed with water 3 times. The concentrations of Au, Pt, Gd, and Fe were determined by ICPÀMS analysis.
Relaxivity Measurement. A series of concentrations of four types of Gd-incorporated NPs (0, 0.0156, 0.0312, 0.0625, 0.125, 0.25, 0.5, and 1 mM Fe; the corresponding Gd concentrations are determined by the molar ratios of Fe to Gd based on Table 1) were prepared by dilution in 1% agarose gel and then were solidified in the 300 μL vials. The longitudinal (r 1 ) and transverse relaxation rates (r 2 ) of various heterostructures (GdÀHNTs, GdÀDB-HNTs, or GdÀXDB-HNTs) were measured using a 7.0-T small animal MRI system with magnetic bore size of 310 mm, including a superconducting magnet (Magnex Scientific) with 7.0 T field strength and a gradient with 120 mm i.d., 600 mT/m of maximum gradient amplitude, and 6000 T/m/s of a maximum slew rate. T 1 -weighted MR images were acquired using fast-spin echo sequences under the following parameters: echo time Cu-XDB-HNTs have modest specific activity (222 MBq/nmol particle, 4 μCi/μg Fe). The serum stability of 64 Cu labeled NPs was performed according to our previous report. 23 Briefly, 64 Cu-DB-HNTs or 64 Cu-XDB-HNTs were incubated in mouse serum at 37°C for up to 24 h. Aliquots of the mixture were removed from the solution at predetermined time intervals and filtered through 30 kDa cutoff filters. The radioactivity of filtrates was then measured. The stability of radiolabels NPs was calculated by the percentages of retained 64 Cu on the NPs to the total activity. Samples were assayed in triplicate.
Cell Culture and Tumor Xenograft Model. The HT-29 (human colorectal adenocarcinoma cell line) cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA). The HT-29 cells were cultured in McCoy's 5a medium [10% heatinactivated FBS and 1% penicillinÀstreptomycin] and propagated as recommended by ATCC. Female nu/nu mice (Charles River Laboratories International, Inc., Wilmington, MA) were housed and maintained in accordance with federal and local institutional rules for the conduct of animal experimentation and received food and water ad libitum. Tumors were generated by harvesting HT-29 cells from mid-log phase cultures using TrypsinÀEDTA (Invitrogen, Inc.). Approximately 4 Â 10 6 HT-29 cells suspended in 100 μL of PBS were subcutaneously implanted in the right shoulders of nude mice. Tumors were allowed to grow to a size of 600À800 mm 3 (3À4 weeks) before imaging experiments.
In Vivo Small-Animal PET/CT of Tumor Mice.
64
Cu-DOTA-HNTs or 64 Cu-DOTA-HNTs (100 μCi in 150 μL PBS) were injected via tail vein into the HT-29 tumor-bearing mice (n = 3) at a dose of 5 mg Fe/kg of mouse weight. In vivo small-animal PET/CT was carried out on a Siemens-Inveon PET-CT (Siemens Medical Solution) according to the previous publications. 31, 32 PET scans were performed at 4 and 24 h post-injection (pi). Mice were anesthetized with isoflurane (5% for induction and 2% for maintenance in 100% O 2 ). With the help of a laser beam attached to the scanner, mice were placed in the prone position and near the center of the field of view (FOV) of the scanner and 5 min static scans were obtained. All the small animal PET images were reconstructed and viewed by the Inveon Research Workplace (IRW). Region of interests (ROIs for coronal and transaxial slices) were drawn over the tumor on decay-corrected whole-body coronal images. Values in 3 to 10 adjacent slices (depending on the size of the tissue or organ) were averaged to obtain a reproducible value of radioactivity concentration. The maximum counts per pixel per minute were obtained from the ROIs and were converted to counts per milliliter per minute using a calibration constant. ROIs were then converted to counts per gram per minute based on the assumption of a tissue density of 1 g/mL, and image ROI-derived percentage of the injected radioactive dose per gram of tissue (%ID/g) values were determined by dividing counts per gram per minute by injected dose. No attenuation correction was performed.
MRI. Mice bearing HT-29 tumor were anesthetized with 2% isoflurane in oxygen and placed with prone position. MRI was performed using the same instrument, protocols, and conditions as in the phantom MRI study. DOTA-DB-HNTs were injected via tail vein into the HT-29 tumor-bearing mice at a ARTICLE dose of 10 mg Fe/kg of mouse weight (n = 3). T 2 -weighted fast spinÀecho MR images were acquired on a 7.0-T small animal MRI system (GE Healthcare) under the following parameters: repetition time (T R ) = 3000 ms, T E = 40 ms, echo train length = 8, FOV = 4 Â 4 cm 2 , section thickness = 1 mm, flip angle = 90°. MR images were acquired in both transverse and coronal direction pre-injection and at 4 and 48 h after injection. Transversal and coronal MR images were acquired and the signal intensities were measured in defined ROIs using OsiriX imaging software (OsiriX version 3.2; Apple Computer). The NIH standard was used for tumor imaging processing. The ROI analysis was performed according to the previous publications. 23 Statistical Method. Measurement data are expressed as the mean ( SD. Statistical analyses of the data were performed using Prism (GraphPad Software). A p-value of less than 0.05 was considered significant.
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